日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis.

AZD1163 的临床前表征,AZD1163 是一种用于治疗类风湿性关节炎的首创抗 PAD2/4 双特异性抗体。

Sims Gary P, Scaletta Lacie, Andrews John, Sims Dorothy A, Strain Martin, Sigurdardottir Anna, Kuriakose Teneema, England Elizabeth, Rajasinghe Lichchavi, Jiang Fanyi, Xiong Ximing, Neal Frances, Vinall Lisa, Newton Philip, Boger Elin, Kim Chong, Dahlbäck Helena, Prothon Susanne, Leander Jacob, Darrah Erika, Collins Mia, Douglas Garry, White Nicholas, Day Katie, Vousden Katherine A, Huntington Catherine E, Close David

Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand.

AMG 329 的开发和临床前表征:一种中和 FLT3 配体的人类抗体

Lau-Kilby Annie, Gunsior Michele, Bartczak Agata, Chyou Susan, Hester James, Sims Dorothy, Xiao Xiaodong, Pavlik Peter, Chen Yan, Casey Kerry A, Zerrouki Kamelia, Wang Qian, Borrok M Jack, Hansen Anna M, Rees William A